ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2

Clinical trial NCT05507216 · COMPLETED

Trial details

NCT number: NCT05507216
Sponsor: Abivax S.A.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2022-12-21
Primary completion: 2025-06-24
Enrollment: 636

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.